LISATA THERAPEUTICS, INC.: accounts_receivable
| Value | {"amount": 2088888, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2014-09-30) |
| Status | current |
| Entity | LISATA THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:30:03.792427+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0db82cf4-76c1-4e3e-932b-8eedb04b2d99
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000320017-14-000070 · Open the official SEC filing →Retrieved: 2026-08-19T07:30:03.792427+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000320017/accounts-receivable/2014-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0db82cf4-76c1-4e3e-932b-8eedb04b2d99
History
- no predecessors — first report